MS vs PG: Which Is the Better Buy?
Side-by-side comparison of Morgan Stanley and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-17.
Morgan Stanley · Financial Services
$206.27
+15.9% upside to fair value
Med Conviction
Grade C
VS
The Procter & Gamble Company · Consumer Defensive
$147.04
+14.4% upside to fair value
Med Conviction
Grade B+
High Quality
QuantHub Verdict
MS has more upside to fair value
(+15.9%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MS |
PG |
| Current Price |
$206.27 |
$147.04 |
| Fair Value Estimate |
$239.00 |
$168.19 |
| Upside to Fair Value |
+15.9%
|
+14.4%
|
| Market Cap |
$325.4B |
$349.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
23.5x
|
17.6x
|
| Price / Sales |
2.6x
|
4.0x
|
| Price / FCF |
—
|
22.4x
|
| Revenue Growth YoY |
+22.4%
|
+1.5%
|
| Gross Margin |
59.7%
|
50.2%
|
| Operating Margin |
20.7%
|
22.7%
|
| Return on Equity |
18.1%
|
29.8%
|
| Dividend Yield |
2.01% |
2.92% |
| FCF Yield |
—
|
4.47%
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
Morgan Stanley is a diversified capital-markets and wealth-management franchise spanning institutional securities, advisor-led and self-directed wealth, workplace services, and investment management. Business quality is solid but inherently cyclical: it combines $8.084 trillion of wealth client assets and $2.004 trillion of investment-management AUM/AUS with a strengthening 15.5% institutional pe…
Procter & Gamble is a global consumer-staples leader selling daily-use products across beauty, grooming, health care, fabric and home care, and baby, feminine and family care in about 180 countries. Business quality is high because its brands, consumer insight, R&D, marketing scale and global distribution underpin leading category positions, including over 60% in blades and razors and over 35% in…
Accumulation Zones
| Metric |
MS |
PG |
| Zone Low |
$179.25 |
$126.14 |
| Zone High |
$203.15 |
$142.96 |
| In Buy Zone? |
No
|
No
|